Matinas BioPharma Holdings, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 114.26 | -100% | -9.07 | -100% |
| P/S |
|
43.41 | 4.1 | 958.01% |
|
|
| P/BV |
|
2.47 | 9.02 | -72.6% |
|
|
| P/FCF |
|
0 | 44.61 | -100% |
|
|
| Ev/Ebitda |
|
-2.03 | 17.72 | -111.45% |
|
|
| Ev/S |
|
42.24 | 4.41 | 858.67% |
|
|
| Ev/FCF |
|
-2.99 | 54.82 | -105.45% |
|
|
| E/P |
|
0 | 0.2136 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2082.57 | 21.49 | -9792.01% | -19816.4 | -89.49% |
| ROE |
|
-119.2 | -82.41 | 44.66% |
|
|
| ROA |
|
-34.98 | 6.75 | -618.22% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-2093.25 | 10.29 | -20445.57% |
|
|
| ROCE |
|
-123.49 | 55.28 | -323.39% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1558 | 1.19 | -113.11% | -0.1636 | -4.77% |
| Nеt Debt/Ebitda |
|
0.0561 | 2.27 | -97.52% |
|
|
| Debt/Ratio |
|
0.0542 | 0.2655 | -79.57% |
|
|
| Debt/Equity |
|
1.69 | 4.81 | -64.81% |
|
|
| Debt/Net Income |
|
-0.155 | 35.64 | -100.43% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.3 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.35 | -100% | ||
| DSI |
|
0 | 0.7478 | -100% |
|
|
| Average dividend growth |
|
0 | -1.67 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.29 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.77 | -100% |
|
|
| Difference from average difference in sector |
|
-1.3 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1117.78 | 214.83 | 420.31% | ||
| Growth impulse Ebitda in 5 years |
|
14.7 | 253.48 | -94.2% | ||
| Growth impulse Net Income in 5 years |
|
47.06 | 270.34 | -82.59% | ||
| Growth impulse FCF in 5 years |
|
6.87 | 183.09 | -96.25% | ||
| Growth impulse EPS in 5 years |
|
4820.54 | 149.95 | 3114.76% |
IP Score
3.86/10
